The effective preventive and therapeutic effects of penfluridol in TNFα-dominant mouse model prompted us to test whether penfluridol had the same therapeutic effect in the diseases in which pathogenesis was dominant by TNFα and TNFα-stimulated NF-κB activation, such as RA and IBD [2]. The gene discussed is NFKB1; the disease is rheumatoid arthritis.